FDA Submission Marks a Pivotal Milestone in Advancing Early Cancer Detection, Addressing Unmet Needs in Cancer Screening MENLO PARK, Calif., Jan. 29, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a ...
NEW YORK--(BUSINESS WIRE)--Paige, a leader in next-generation AI technology, today announced an expansion of Paige PanCancer Detect, the first AI application capable of identifying cancer across a ...
Patent covers pristine graphene–based biosensor technology to translate protease activity into measurable optical ...
NEWTON, Mass.--(BUSINESS WIRE)--Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced the U.S. Food and Drug ...
A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...
Morning Overview on MSN
Photonics and nanotech may detect cancer signals 5 to 8 years early
Scientists working at the intersection of photonics and nanotechnology are building tools that could identify cancer-related ...
Cancer is one of the leading causes of death globally, with nearly 20 million new cases and 9.7 million deaths in 2022. Early detection plays a crucial role in reducing cancer-related morbidity and ...
The prospect of diagnosing cancer through painless methods - such as a simple AI-assisted blood or urine test that detects tiny particles known as exosomes - is becoming increasingly realistic.
The race for early cancer detection is one that physicians have been running for millennia. In one of humanity’s oldest surviving medical texts, the ancient Egyptian physician Imhotep described 46 ...
Liquid biopsy encompasses a variety of molecular approaches to detect circulating tumor DNA (ctDNA) and has become a powerful tool in the diagnosis and treatment of solid tumors. Current applications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results